Recently, a mouse model of hereditary tyrosinemia type I(HT1)caused by a point mutation of fumarylacetoacetate hydrolase (FAH) was phenotypically restored via Cas9‐mediated gene repair in vivo (Yin et al, 2014). The gene discussed is FAH; the disease is tyrosinemia type I.